The mission of the Center for Biotechnology (CFB) is to catalyze the translation of basic biomedical sciences into diagnostic and therapeutic technologies that benefit human health and society, and fuel economic growth.
Based at SUNY Stonybrook, the CFB has a well established history of driving innovation toward commercial goals resulting in accelerated product development cycles, new employment opportunities, and increased corporate revenues.
CFB investments in technology development have contributed to eighteen new company startups in the pharmaceutical, biotechnology and medical device industries, while accelerating thirteen new products to the marketplace, including ReoPro™, Periostat®, Cavistat®, the V3D Colon™ virtual colonoscopy, SAFHS™ and Dynamic Motion Therapy™..
Designated as a New York State Center for Advanced Technology (CAT) in Medical Biotechnology, the CFB was established in 1983 as a cooperative research and development partnership between universities, private industry and government. The primary objective of the CFB is to generate positive economic impact in the form of new and retained jobs, corporate revenues and cost savings, as well as leveraged funding from private and public sources, primarily by capitalizing on the unique research capabilities of academic institutions to drive and support a globally competitive, knowledge-based economy in New York State.